• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

InSight posts another profitable quarter

Article

During a period of uncertainty over new Medicare rules (SCAN, 5/24/00), InSight Health Services of Newport Beach, CA, reported a profit for the quarter ended June 30 and for the year.The company reported revenue for the year up 16% to

During a period of uncertainty over new Medicare rules (SCAN, 5/24/00), InSight Health Services of Newport Beach, CA, reported a profit for the quarter ended June 30 and for the year.

The company reported revenue for the year up 16% to $188.6 million from $162 million for the year ended June 30. Total revenue for the previous quarter was up 10% to $48.6 million from $44.4 million for the previous quarter.

InSight’s profit for the year increased 17% to $7.2 million, compared with $6.1 million for the previous year. Profit for the quarter ended June 30 increased 33% to $2.6 million, compared with $1.9 million for the previous quarter. The company said a major reason has been a reduction in expenses.

The new Medicare rules that went into effect Aug. 1 threaten to cut payments for hospital outpatient radiology procedures (SCAN 5/10/00). Nonhospital providers, however, may be reimbursed the full amount for outpatient radiology services, a boon to some imaging companies.

One factor causing problems for several large imaging services companies is that the competitive environment for centers varies considerably from region to region.

InSight operates imaging centers in 30 U.S. states (including a major presence in Texas).

Recent Videos
Can an Emerging AI Software for DBT Help Reduce Disparities in Breast Cancer Screening?
Skeletal Muscle Loss and Dementia: What Emerging MRI Research Reveals
Magnetoencephalopathy Study Suggests Link Between Concussions and Slower Aperiodic Activity in Adolescent Football Players
Radiology Study Finds Increasing Rates of Non-Physician Practitioner Image Interpretation in Office Settings
Assessing a Landmark Change in CMS Reimbursement for Diagnostic Radiopharmaceuticals
Addressing the Early Impact of National Breast Density Notification for Mammography Reports
2 KOLs are featured in this series.
2 KOLs are featured in this series.
Can 18F-Floutufolastat Bolster Detection of PCa Recurrence in Patients with Low PSA Levels After Radical Prostatectomy?
2 KOLs are featured in this series.
Related Content
© 2024 MJH Life Sciences

All rights reserved.